Skip to content
Events

Details

Esta sesión proporciona una descripción general de cómo las aplicaciones para enfermedades infecciosas y microbiología de la serie MiSeqᵀᴹ i100 pueden respaldar la vigilancia genómica para gestionar brotes de enfermedades, controlar las infecciones asociadas a la atención sanitaria (HAI), abordar la resistencia a los antimicrobianos (AMR) o simplemente obtener más información de sus muestras biológicas utilizando Metagenómica y Metatranscriptómica.

Julen Ortiz de Zarate​
Executive Specialist, Commercial Expansion & Partnerships, Europe​

Complete el formulario para acceder al seminario web

Your email address is never shared with third parties.

Date & Time
12 Nov 2024
Location
Spain
Europe
Presenter
Julen Ortiz de Zarate​
Topic
Microbial genomics
Watch Now
 
 
M-EMEA-01741
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.